MENU
+Compare
ESLOY
Stock ticker: OTC
AS OF
Oct 16 closing price
Price
$177.13
Change
+$19.21 (+12.16%)
Capitalization
144.57B

ESLOY stock forecast, quote, news & analysis

EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses... Show more

ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ESLOY with price predictions
Oct 16, 2025

ESLOY's RSI Oscillator reaches into overbought territory

The RSI Indicator for ESLOY moved into overbought territory on October 16, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESLOY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ESLOY broke above its upper Bollinger Band on October 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where ESLOY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 16, 2025. You may want to consider a long position or call options on ESLOY as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ESLOY just turned positive on October 16, 2025. Looking at past instances where ESLOY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESLOY advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 295 cases where ESLOY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.723) is normal, around the industry mean (10.730). P/E Ratio (59.291) is within average values for comparable stocks, (53.572). ESLOY's Projected Growth (PEG Ratio) (3.223) is slightly higher than the industry average of (1.779). Dividend Yield (0.013) settles around the average of (0.016) among similar stocks. P/S Ratio (5.176) is also within normal values, averaging (13.562).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ESLOY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

ESLOY paid dividends on June 26, 2025

EssilorLuxottica ESLOY Stock Dividends
А dividend of $4.50 per share was paid with a record date of June 26, 2025, and an ex-dividend date of May 12, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.97B. The market cap for tickers in the group ranges from 246 to 155.8B. ISRG holds the highest valuation in this group at 155.8B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 14%. FEMY experienced the highest price growth at 15%, while PDEX experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 219%. For the same stocks of the Industry, the average monthly volume growth was 104% and the average quarterly volume growth was 171%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 63
Price Growth Rating: 79
SMR Rating: 100
Profit Risk Rating: 91
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
147, Rue de Paris
Phone
+33 149774224
Employees
190000
Web
https://www.essilorluxottica.com